관상동맥 질환에서 압력철선의 유용성 = Role of Pressure Wire in Coronary Artery Disease

다국어 초록 (Multilingual Abstract)

To get the best clinical outcome after revascularization, understanding of patient and lesion should proceed. Although coronary angiography has been regarded as the gold standard for assessing coronary artery disease for several decades, it has several well-known limitations. Fractional flow reserve (FFR), measured with a coronary pressure wire, is an accurate and lesion-specific index for determining the functional significance (myocardial ischemia) of a particular stenosis. The selection of target vessels, the decision and method for revascularization, and the determination of prognosis in patients with CAD can be helped by FFR in daily practice. In this manuscript, we will review the role of pressure wire and discuss the limitation of it in evaluating CAD. (Korean J Med 2011;81:708-715)

참고문헌 (Reference)

1 Marcus ML, "Visual estimates of percent diameter coronary stenosis: "a battered gold standard"" 11 : 882-885, 1988

2 Wykrzykowska JJ, "Value of the syntax score for risk assessment in the all-comers population of the randomized multicenter LEADERS (limus eluted from a durable versus erodable stent coating) trial" 56 : 272-277, 2010

3 Kang SJ, "Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity" 4 : 65-71, 2011

4 Lopez-Palop R, "Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis" 25 : 2040-2047, 2004

5 Nam CW, "Usefulness of Coronary Pressure Measurement for Functional Evaluation of Drug-Eluting Stent Restenosis" EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC 107 (107): 1783-1786, 2011

6 Moses JW, "Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery" 349 : 1315-1323, 2003

7 De Bruyne B, "Simultaneous coronary pressure and flow velocity measurements in humans: feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve" 94 : 1842-1849, 1996

8 Nam CW, "Relation of fractional flow reserve after drug-eluting stent implantation to one-year outcomes" 107 : 1763-1767, 2011

9 De Bruyne B, "Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia" 92 : 39-46, 1995

10 Grines CL, "Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians" 69 : 334-340, 2007

11 Fearon WF, "Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction" 51 : 560-565, 2008

12 Koo BK, "Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve" 29 : 726-732, 2008

13 Kern MJ, "Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology" 114 : 1321-1341, 2006

14 Koo BK, "Physiologic assessment of jailed side branch lesions using fractional flow reserve" 46 : 633-637, 2005

15 Pijls NH, "Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study" 49 : 2105-2111, 2007

16 Nam CW, "Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: fractional flow reserve-guided versus intravascular ultrasoundguided" 3 : 812-817, 2010

17 Pijls NH, "Optimum guidance of complex PCI by coronary pressure measurement" 90 : 1085-1093, 2004

18 Koo BK, "Optimal intravascular ultrasound criteria and their accuracy for defining the functional significance of intermediate coronary stenoses of different locations" 4 : 803-811, 2011

19 Fearon WF, "Novel index for invasively assessing the coronary microcirculation" 107 : 3129-3132, 2003

20 Virmani R, "Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans" 106 : 2649-2651, 2002

21 Pijls NH, "Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses" 334 : 1703-1708, 1996

22 Wijns W, "Guidelines on myocardial revascularization" 31 : 2501-2555, 2010

23 Nam CW, "Functional SYNTEX score for risk assessment in multivessel coronary artery disease" 58 : 1211-1218, 2011

24 Pijls NH, "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study" 56 : 177-184, 2010

25 Tonino PA, "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention" 360 : 213-224, 2009

26 Bech GJ, "Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial" 103 : 2928-2934, 2001

27 De Bruyne B, "Fractional flow reserve in patients with prior myocardial infarction" 104 : 157-162, 2001

28 Ntalianis A, "Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction" 3 : 1274-1281, 2010

29 남창욱, "Fractional Flow Reserve Versus Angiography in Left Circumflex Ostial Intervention After Left Main Crossover Stenting" 대한심장학회 41 (41): 304-307, 2011

30 Koo BK, "FFR in bifurcation stenting: what have we learned" 6 (6): J94-J98, 2010

31 Pijls NH, "Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty" 87 : 1354-1367, 1993

32 Fearon WF, "Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease" 122 : 2545-2550, 2010

33 Yan BP, "Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation" 7 : 155-158, 2006

34 Cohen DJ, "Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the sirolimus-eluting balloon expandable stent in the treatment of patients with De Novo Native Coronary Artery Lesions (SIRIUS) trial" 110 : 508-514, 2004

35 Pijls NH, "Coronary pressure measurement to assess the hemodynamic significance of serial stenoses within one coronary artery: validation in humans" 102 : 2371-2377, 2000

36 Pijls NH, "Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry" 105 : 2950-2954, 2002

37 Serruys PW, "Assessment of the SYNTAX score in the Syntax Study" 5 : 50-56, 2009

38 Meneses Hoyos J, "Angiography of the thoracic aorta and coronary vessels, with direct injection of an opaque solution into the aorta" 50 : 211-213, 1948

39 Tonino PA, "Angiographic versus functional severity of coronary artery stenoses in the FAME Study fractional flow reserve versus angiography in multivessel evaluation" 55 : 2816-2821, 2010

40 Kushner FG, "2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines" 120 : 2271-2306, 2009